Literature DB >> 9593123

A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.

J Blázquez1, M C Negri, M I Morosini, J M Gómez-Gómez, F Baquero.   

Abstract

A TEM-1 beta-lactamase derivative containing the single amino acid substitution A237T slightly increased (from 24 to 32 microg/ml) the cephalothin MIC for Escherichia coli RYC1000 but did not influence the activities of cefotaxime, ceftazidime, and aztreonam (MICs of 0.03, 0.12, and 0.06 microg/ml, respectively). Despite its apparent neutrality, addition of the A237T mutation to the pair of mutations characterizing TEM-10 (R164S and E240K) had a strong effect on substrate preference. Ceftazidime and aztreonam MICs decreased from 128 and 16 microg/ml to 16 and 2 microg/ml, respectively. In contrast, the cefotaxime MIC increased from 0.5 to 4 microg/ml. The acquisition of apparently neutral or even deleterious mutations results in a very effective mechanism of resistance to different beta-lactams that may be simultaneously or subsequently present in the environment. We propose here that the mutation in position 237 is an example of a modulating mutation and that consideration of this type of mutation may be important for understanding the evolution of beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593123      PMCID: PMC105741          DOI: 10.1128/AAC.42.5.1042

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  A standard numbering scheme for the class A beta-lactamases.

Authors:  R P Ambler; A F Coulson; J M Frère; J M Ghuysen; B Joris; M Forsman; R C Levesque; G Tiraby; S G Waley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

Review 2.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

3.  Substrate specificities in class A beta-lactamases: preference for penams vs. cephems. The role of residue 237.

Authors:  W J Healey; M R Labgold; J H Richards
Journal:  Proteins       Date:  1989

4.  Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase.

Authors:  J Péduzzi; M Barthélémy; K Tiwari; D Mattioni; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

5.  Limits of adaptation: the evolution of selective neutrality.

Authors:  D L Hartl; D E Dykhuizen; A M Dean
Journal:  Genetics       Date:  1985-11       Impact factor: 4.562

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 7.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

8.  Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu.

Authors:  M J Casadaban
Journal:  J Mol Biol       Date:  1976-07-05       Impact factor: 5.469

9.  Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9.

Authors:  B G Spratt; P J Hedge; S te Heesen; A Edelman; J K Broome-Smith
Journal:  Gene       Date:  1986       Impact factor: 3.688

10.  Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam.

Authors:  J A Sowek; S B Singer; S Ohringer; M F Malley; T J Dougherty; J Z Gougoutas; K Bush
Journal:  Biochemistry       Date:  1991-04-02       Impact factor: 3.162

View more
  16 in total

1.  Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.

Authors:  L Poirel; I Le Thomas; T Naas; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Detection of five novel CTX-M-type extended spectrum beta-lactamases with one to three CTX-M-14 point mutations in isolates from Hefei, Anhui province, China.

Authors:  Hui Li; Jia Bin Li
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 3.  Genetic constraints on protein evolution.

Authors:  Manel Camps; Asael Herman; Ern Loh; Lawrence A Loeb
Journal:  Crit Rev Biochem Mol Biol       Date:  2007 Sep-Oct       Impact factor: 8.250

Review 4.  Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance.

Authors:  Fernando Baquero; Teresa M Coque; Fernando de la Cruz
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

5.  Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Jocelyne Caillon; Melissa D Barnes; Gilles Potel; Saralee Bajaksouzian; Joseph D Rutter; Amokrane Reghal; Stuart Shapiro; Magdalena A Taracila; Michael R Jacobs; Robert A Bonomo; Cédric Jacqueline
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

6.  Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Magdalena Taracila; John M Hornick; Andrea M Hujer; Kristine M Hujer; Anne M Distler; Andrea Endimiani; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

7.  Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.

Authors:  Krisztina M Papp-Wallace; Saralee Bajaksouzian; Ayman M Abdelhamed; Altreisha N Foster; Marisa L Winkler; Julian A Gatta; Wright W Nichols; Raymond Testa; Robert A Bonomo; Michael R Jacobs
Journal:  Diagn Microbiol Infect Dis       Date:  2015-02-14       Impact factor: 2.803

8.  Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure.

Authors:  J Blazquez; M I Morosini; M C Negri; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

9.  Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.

Authors:  Juan-Carlos Galán; María-Isabel Morosini; María-Rosario Baquero; Milagro Reig; Fernando Baquero
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

10.  Fitness trade-offs in blaTEM evolution.

Authors:  Joanna E Mroczkowska; Miriam Barlow
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.